Continuous Telemonitoring of Heart Failure using Personalised Speech Dynamics

Remote monitoring of heart failure (HF) via speech signals provides a non-invasive and cost-effective solution for long-term patient management. However, substantial inter-individual heterogeneity in vocal characteristics often limits the accuracy of traditional cross-sectional classification models. To address this, we propose a Longitudinal Intra-Patient Tracking (LIPT) scheme designed to capture the trajectory of relative symptomatic changes within individuals. Central to this framework is a Personalised Sequential Encoder (PSE), which transforms longitudinal speech recordings into context-aware latent representations. By incorporating historical data at each timestamp, the PSE facilitates a holistic assessment of the clinical trajectory rather than modelling discrete visits independently. Experimental results from a cohort of 225 patients demonstrate that the LIPT paradigm significantly outperforms the classic cross-sectional approaches, achieving a recognition accuracy of 99.7% for clinical status transitions. The model's high sensitivity was further corroborated by additional follow-up data, confirming its efficacy in predicting HF deterioration and its potential to secure patient safety in remote, home-based settings. Furthermore, this work addresses the gap in existing literature by providing a comprehensive analysis of different speech task designs and acoustic features. Taken together, the superior performance of the LIPT framework and PSE architecture validates their readiness for integration into long-term telemonitoring systems, offering a scalable solution for remote heart failure management.

DiffDTM: A conditional structure-free framework for bioactive molecules generation targeted for dual proteins

Advances in deep generative models shed light on de novo molecule generation with desired properties. However, molecule generation targeted for dual protein targets still faces formidable challenges including protein 3D structure data requisition for model training, auto-regressive sampling, and model generalization for unseen targets. Here, we proposed DiffDTM, a novel conditional structure-free deep generative model based on a diffusion model for dual targets based molecule generation to address the above issues. Specifically, DiffDTM receives protein sequences and molecular graphs as inputs instead of protein and molecular conformations and incorporates an information fusion module to achieve conditional generation in a one-shot manner. We have conducted comprehensive multi-view experiments to demonstrate that DiffDTM can generate drug-like, synthesis-accessible, novel, and high-binding affinity molecules targeting specific dual proteins, outperforming the state-of-the-art (SOTA) models in terms of multiple evaluation metrics. Furthermore, we utilized DiffDTM to generate molecules towards dopamine receptor D2 and 5-hydroxytryptamine receptor 1A as new antipsychotics. The experimental results indicate that DiffDTM can be easily plugged into unseen dual targets to generate bioactive molecules, addressing the issues of requiring insufficient active molecule data for training as well as the need to retrain when encountering new targets.